Take Whatever the Market Is Giving You<br />By Rev Shark<br />RealMoney.com Contributor<br />6/3/2009 8:29 AM EDT <br /><br />The superior person can hold two contradictory thoughts simultaneously and still continue to function. You need a long-term vision combined with short-term focus. <br />-- Brian Tracy<br /><br />I keep reading stories about how wonderful things are going for the economy -- home and car sales increasing, consumer sentiment jumping, inflation well under control and green shoots of recovery everywhere. Given how the stock market has been acting, a lot of folks are embracing these optimistic views. <br /><br />The debate between those (like Jim Cramer) who think things really are rapidly improving and aren't fully reflected in the market. and those (like Doug Kass) who think the market has gotten ahead of itself is going to be the primary theme we read about for quite some time. No matter what side of the argument you agree with, the key thing is that you not let economic arguments blind you to the way that stocks are actually performing. <br /><br />I have great concerns about the eventual repercussions of all the government involvement in the economy. Handing out money is something the government does well, but paying the bill down the road is going to be the big challenge. Although there are already growing fears of inflation and concerns about government intrusion into private business, the market isn't reflecting those worries at all. In fact, the market seems to be indicating that things are going to work out very well. <br /><br />The easy thing to do is to be dogmatic and adopt either the extremely rosy view or the extremely pessimistic view. Most everyone has a strong opinion and is leaning one way or the other. <br /><br />The most practical approach for investors is let the market be your guide to the economy. Right now the market is acting like the economy is going to be just fine. While we are a bit toppy in the short term, nothing in the technical action indicates anything other than blue skies and apple pies ahead of us. We have strong speculative action, a growing list of stocks hitting new highs, rising commodity prices and stocks making parabolic moves. You might not believe what this is indicating about the economy, but trying to fight it isn't going to make you much money in the near term. <br /><br />At some point the indices are going to struggle and even lose some underlying support. At that point we can start worrying more about the validity of the views of the economic pessimists. I believe the market won't make it through the summer unscathed by a pretty severe pullback, but that is not today's business. Today's business is navigating a market that is still acting quite well. <br />-----------------------------<br />Ülespoole avanevad:<br /><br />In reaction to strong earnings/guidance: APSG +11.8%, TSRA +11.7% (also enters into technology license agreement with Motorola), BOBE +9.3%, FE +6.0%, JOYG +1.0%... M&A news: DDUP +3.1% (NetApp raises DDUP acquisition offer to $30/share in cash and stock)... Other news: TIVO +46.1% (confirms Court rejected EchoStar's "attempted workaround claim" regarding the TiVo patent), PPHM +25.0% (highlights "promising early data" from its three Phase II bavituximab cancer trials), SAY +17.8% (SEBI OKs Tech Mahindra open offer - WSJ), SGY +11.9% (announces deepwater discovery on Pyrenees Prospect), CTIC +11.6% (announces that patients with cancer of the lower esophagus had evidence of a high pathological complete response rate when given OPAXIO), IPAS +11.4% (to return up to $40 mln of capital to stockholders), PMI +6.6% (The PMI Group ratings raised by Standard & Poor's), CHLN +6.1% (still checking), HEB +4.4% (continued momentum from yesterday's 25%+surge higher)... Analyst comments: AAI +7.0% (upgraded to Buy from Underperform at BofA/Merrill), PLT +3.5% (upgraded to Overweight from Neutral at JP Morgan), EBAY +1.3% (upgraded to Buy at Collins Stewart). <br /><br />Allapoole avanevad:<br /><br />In reaction to disappointing earnings/guidance: VLO -11.8% (also announces 40 mln common share offering; downgraded to Underperform from Mkt Perform at BMO Capital), AET -7.0% (downgraded to Underperform at Credit Suisse and downgraded to Market Perform from Outperform at Wachovia), PAY -6.7%, BCSI -3.3%... Select financial related names trading lower: RBS -5.9%, BCS -5.6%, HBC -4.2%, UBS -3.8%, LYG -3.8%, MET -1.7%, C -1.6%... Select metals/mining names showing weakness: AAUK -4.0%, GFI -4.0%, BBL -3.4%, MT -3.4%, RTP -2.6%, GOLD -2.1%, GG -1.9%, KGC -1.9% (downgraded to Neutral from Overweight at JP Morgan), BHP -1.7%, AUY -1.5%... Select managed healthcare names trading lower in sympathy with AET guidance: CI -4.1%, WLP -4.0%, HUM -4.0%, UNH -3.9%, CAH -1.5% (downgraded to Neutral at Baird)... Select refiners and oil/gas related names showing weakness partially attributed to VLO guidance: HOC -7.2%, TSO -5.1%, SUN -3.3%, REP -2.9%, RDS.A -2.9%, WNR -2.7%, CHK -2.5%, TOT -1.9%, MRO -1.5%, E -1.5%, BP -1.4%, CVX -1.1%... Other news: FFBC -10.2% (trading ex-dividend), STLD -8.0% (announces proposed offerings of 27 mln shares common stock and $150 mln aggregate amount of convertible senior notes), NGG -6.7% (trading ex-dividend), JBLU -6.6% (announces proposed offerings of 20 mln shares of common stock and $150 mln of convertible debentures), DISH -6.3% (confirms court's decision finding co in contempt), ACGY -6.2% (still checking), PRU -4.1% (prices 32,051,283 common share offering at $39/share), HBAN -3.6% (announces a $300 mln common equity public offering and suspension of current discretionary equity issuance program), LAZ -3.3% (Certain Lazard Ltd shareholders sell common four mln shares of stock in a secondary offering), BKD -1.8% (prices 13,953,489 follow-on common share offering at $10.75/share)... Analyst comments: AMSC -4.1% (downgraded to Underweight at Morgan Stanley), CUB -3.1% (downgraded to Hold at BB&T), NG -2.1% (downgraded to Underperform at RBC Capital), VMW -1.9% (initiated with a Sell at Ladenburg), BRCD -1.6% (Goldman Sachs removes from Americas Conviction Buy list; maintains Buy - Reuters).